PIERDOMENICO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 906
EU - Europa 181
AS - Asia 143
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.232
Nazione #
US - Stati Uniti d'America 891
IT - Italia 77
CN - Cina 52
SG - Singapore 46
IN - India 30
SE - Svezia 27
FI - Finlandia 21
DE - Germania 19
CA - Canada 10
UA - Ucraina 9
TR - Turchia 7
GB - Regno Unito 5
BZ - Belize 4
IE - Irlanda 4
RO - Romania 4
RU - Federazione Russa 4
BE - Belgio 3
BG - Bulgaria 3
ID - Indonesia 2
JP - Giappone 2
AZ - Azerbaigian 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.232
Città #
Fairfield 154
Chandler 83
Seattle 79
Woodbridge 76
Ashburn 59
Wilmington 58
Cambridge 56
Houston 53
Singapore 38
Rome 35
Beijing 25
San Paolo di Civitate 23
Princeton 20
Plano 16
Lawrence 15
Ann Arbor 14
Santa Clara 14
San Jose 13
Millbury 12
New York 8
San Diego 8
Boston 7
Helsinki 7
Istanbul 7
Ottawa 7
Andover 6
Norwalk 6
Falkenstein 5
Las Vegas 5
Belize City 4
Dublin 4
Los Angeles 4
Nanjing 4
Saint Louis 4
San Pietro in Cariano 4
Bollate 3
Brussels 3
Buffalo 3
Hefei 3
Iasi 3
Albuquerque 2
Baotou 2
Columbus 2
Fremont 2
Guangzhou 2
Jacksonville 2
Jakarta 2
Kunming 2
Milan 2
Montréal 2
Moscow 2
Redwood City 2
Shenyang 2
Southend 2
Absecon 1
Aigaleo 1
Altopascio 1
Baku 1
Bremen 1
Capranica 1
Changsha 1
Chicago 1
Dearborn 1
Decatur 1
Falls Church 1
Florence 1
Grafing 1
Grottaglie 1
Indiana 1
Jinan 1
Langfang 1
Lido 1
Mainz 1
Manila 1
Mazzano Romano 1
Mexico City 1
Nürnberg 1
Omegna 1
Phoenix 1
Provo 1
Pune 1
Redmond 1
Riga 1
Riyadh 1
Salerno 1
Sant'antimo 1
Shanghai 1
Shijiazhuang 1
Sofia 1
Tel Aviv 1
Toronto 1
Totale 1.013
Nome #
RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells 116
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 98
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase 96
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation 93
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease 93
Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation 86
Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease 84
NOD2 and inflammation: current insights 81
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease 80
New Insights Into the Pathogenesis of Inflammatory Bowel Disease: Transcription Factors Analysis in Bioptic Tissues From Pediatric Patients 80
NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells 79
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis 76
Presenting features and disease course of pediatric ulcerative colitis. 72
Validating the Role of Necroptosis in Inflammatory Bowel Disease (IBD) Pathogenesis 70
Mapping histologic patchiness of celiac disease by push enteroscopy 65
Activated Rip2 kinase is overexpressed in the intestinal mucosa of adult and pediatric inflammatory bowel disease patients and may represent a novel therapeutic target. 49
Totale 1.318
Categoria #
all - tutte 3.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 0 0 0 0 0 51 43 36 28 14 15
2020/2021141 25 11 0 3 6 8 4 6 18 33 12 15
2021/2022198 0 4 35 1 19 13 5 16 14 15 32 44
2022/2023238 40 65 18 25 21 15 4 16 21 5 5 3
2023/202489 3 13 0 6 10 13 1 14 0 14 8 7
2024/202580 7 2 11 9 26 23 2 0 0 0 0 0
Totale 1.318